Guangdong VTR Bio-Tech's (SHE:300381) unit, Hunan Kangjie Biotechnology, agreed to sell equipment to Huasai Biotechnology (Changde) for 35.8 million yuan, according to a Shenzhen Stock Exchange disclosure on Tuesday.
The transferred equipment included 44 types of exclusive equipment, such as flat-plate scraper unloading automatic centrifuge and steel-lined PE ion exchange column diaphragm filter press, the Chinese manufacturer of feed additives and veterinary medicine powder said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。